☆ 4.6 Article

Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development

FRONTIERS IN ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Chemistry, Multidisciplinary

Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines

Jing Liu et al.

Summary: Cancer vaccines aim to stimulate tumor-specific immune responses while sparing normal tissues, with bioinspired materials and technologies playing a role in reshaping the field of cancer nanomedicine. By mimicking desirable properties in nature, bioinspired engineering of cancer vaccine delivery platforms can enhance therapeutic efficacy and safety profiles for clinical translation.

ADVANCED MATERIALS (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Identification of neoantigens for individualized therapeutic cancer vaccines

Franziska Lang et al.

Summary: This Review discusses the use of tumor-specific neoantigens in anticancer vaccines and introduces the mechanisms of neoantigen T cell recognition, as well as computational approaches to predict which neoantigens might confer proficient antitumor immunity in patients. Individualized treatment approaches are required to harness the full potential of the unique cancer mutations in each patient. Computational algorithms and machine-learning tools can be used to identify mutations, prioritize T cell-recognized antigens, and design personalized vaccines for each patient.

NATURE REVIEWS DRUG DISCOVERY (2022)

添加到收藏夹

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Genetics & Heredity

The association between tumor mutational burden and prognosis is dependent on treatment context

Cristina Valero et al.

Summary: High tumor mutational burden (TMB) is associated with improved immunotherapy response, but may lead to poorer survival in patients who have not been treated with immune checkpoint inhibitors.

NATURE GENETICS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Epigenetic modulation of antitumor immunity for improved cancer immunotherapy

Enyong Dai et al.

Summary: Epigenetic mechanisms play important roles in cancer initiation and immune cell function, with the potential to impact tumor microenvironment and therapeutic efficacy by modulating immune cell populations and promoting transcriptional and metabolic reprogramming. By regulating immune-associated genes and immune checkpoint molecules, epigenetic modulating agents can enhance tumor immunogenicity and facilitate anti-tumor immune responses.

MOLECULAR CANCER (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

mRNA vaccine: a potential therapeutic strategy

Yang Wang et al.

Summary: mRNA vaccines have great potential in fighting cancer and viral diseases, with advancements in sequence optimization and delivery strategies to enhance efficacy and stability, and importance in increasing antigen reactivity.

MOLECULAR CANCER (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

mRNA vaccine for cancer immunotherapy

Lei Miao et al.

Summary: mRNA vaccines have emerged as a promising platform for cancer immunotherapy, showcasing high potency, safe administration, rapid development potentials, and cost-effective manufacturing. However, challenges such as stability, innate immunogenicity, and inefficient in vivo delivery restrict their applications. In addressing these challenges, structural modifications and formulation methods are being researched to enhance the anti-tumor immune response.

MOLECULAR CANCER (2021)

添加到收藏夹

Article Oncology

Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase

Cristina Valero et al.

Summary: This study confirmed higher response rates for tumors with TMB of 10 or more mutations per megabase following immune checkpoint inhibitor therapy across multiple cancer types. However, the predictive value of a universal numerical threshold for high TMB was limited, indicating a need for further investigation.

JAMA ONCOLOGY (2021)

添加到收藏夹

Article Immunology

Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer

Pengjun Qiu et al.

Summary: The study found that the exosome-related risk model is associated with the prognosis and immune cell infiltration ratio in patients with triple-negative breast cancer. Patients in the low-risk group had higher survival rates and increased immune cell infiltration compared to the high-risk group.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Clinical and immunological effects of mRNA vaccines in malignant diseases

Annkristin Heine et al.

Summary: mRNA-based therapeutics are considered as a novel and efficient class of drugs, with recent studies demonstrating their potential efficacy in treating various malignant and infectious diseases. Direct application of mRNA or electroporation into dendritic cells can induce immune responses and produce protective antibodies.

MOLECULAR CANCER (2021)

添加到收藏夹

Article Mathematical & Computational Biology

P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma

Xiangfeng Jin et al.

Summary: This study evaluated the functional and clinical values of P3H4 in lung adenocarcinoma (LUAD) and found that P3H4 may promote LUAD progression through regulating tumor microenvironment-related pathways.

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2021)

添加到收藏夹

Review Immunology

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape

Chiranjib Chakraborty et al.

Summary: mRNA vaccines have emerged as a significant type of therapeutic, especially with the recent approval of COVID-19 mRNA vaccines. These vaccines have sparked interest in the pharmaceutical and biotechnology industries, offering new hope for the future of medicine.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Development and Delivery Systems of mRNA Vaccines

Tiancai Liu et al.

Summary: mRNA vaccine development has made significant progress in individualized tumor vaccines. While the production process is simple and safety profiles are good, inherent limitations such as degradation and side effects still exist. Appropriate carriers can enhance immune responses, improve biocompatibility, and biosafety.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

添加到收藏夹

Review Oncology

Advances in bladder cancer biology and therapy

Linda Tran et al.

Summary: Recent developments in bladder cancer research have focused on identifying mutated genes, understanding cellular aspects, and advancing non-invasive diagnostic methods. Immune checkpoint inhibitor therapeutics have shown significant therapeutic impact, providing patients with better monitoring options and hope for prolonged survival.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Article Oncology

Treatment of muscle-invasive and advanced bladder cancer in 2020

Vaibhav G. Patel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Patrick A. Ott et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer

Chuanyu Cheng et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

添加到收藏夹

Review Medicine, General & Internal

Bladder Cancer: A Review

Andrew T. Lenis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Review Immunology

Therapeutic strategies to remodel immunologically cold tumors

Minyu Wang et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)

添加到收藏夹

Review Oncology

Turning Cold into Hot: Firing up the Tumor Microenvironment

Qianqian Duan et al.

TRENDS IN CANCER (2020)

添加到收藏夹

Article Oncology

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Alexandros Papachristofilou et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

Yingyao Zhou et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

添加到收藏夹

Review Physiology

THE TNF FAMILY OF LIGANDS AND RECEPTORS: COMMUNICATION MODULES IN THE IMMUNE SYSTEM AND BEYOND

Catherine Dostert et al.

PHYSIOLOGICAL REVIEWS (2019)

添加到收藏夹

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

mRNA vaccines - a new era in vaccinology

Norbert Pardi et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

添加到收藏夹

Review Immunology

Towards personalized, tumour-specific, therapeutic vaccines for cancer

Zhuting Hu et al.

NATURE REVIEWS IMMUNOLOGY (2018)

添加到收藏夹

Article Cell Biology

Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation

Sara K. Donnelly et al.

JOURNAL OF CELL BIOLOGY (2017)

添加到收藏夹

Article Urology & Nephrology

Landmarks in the treatment of muscle-invasive bladder cancer

Niyati Lobo et al.

NATURE REVIEWS UROLOGY (2017)

添加到收藏夹

Article Cell Biology

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong et al.

CELL REPORTS (2017)

添加到收藏夹

Article Medicine, General & Internal

Bladder cancer

Oner Sanli et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

添加到收藏夹

Article Oncology

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells

Taiwen Li et al.

CANCER RESEARCH (2017)

添加到收藏夹

Review Immunology

Mechanisms and consequences of Jak-STAT signaling in the immune system

Alejandro V. Villarino et al.

NATURE IMMUNOLOGY (2017)

添加到收藏夹

Article Oncology

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

Hubert Kuebler et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)

添加到收藏夹

Article Oncology

Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

John D. Hainsworth et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

添加到收藏夹

Editorial Material Oncology

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Ethan Cerami et al.

CANCER DISCOVERY (2012)

添加到收藏夹

Article Oncology

Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients

Benjamin Weide et al.

JOURNAL OF IMMUNOTHERAPY (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.